Compounds > 1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine

1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine and tetradecanoylphorbol acetate

1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine has been researched along with tetradecanoylphorbol acetate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bianchi, L; Cellai, C; Della Malva, N; Laurenzana, A; Paoletti, F; Vannucchi, AM	1
Al-Hassani, M; Darst, M; Lewis, DA; Li, T; Travers, JB; Travers, JM; Yi, Q	1

Other Studies

2 other study(ies) available for 1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine and tetradecanoylphorbol acetate

Article	Year
Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:7 Topics: Animals; Antineoplastic Agents; Azepines; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Histones; HL-60 Cells; Humans; K562 Cells; Kinetics; Leukemia; Leukemia, Erythroblastic, Acute; Mice; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Triazoles; Tumor Cells, Cultured	2002
Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. Journal of immunology (Baltimore, Md. : 1950), 2004, May-15, Volume: 172, Issue:10 Topics: Adjuvants, Immunologic; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Chromans; Cytokines; Etoposide; Humans; Interleukin-8; KB Cells; Mitomycin; NF-kappa B; Oxidative Stress; Phospholipid Ethers; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transduction, Genetic	2004

Article

Year

Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:7

Topics: Animals; Antineoplastic Agents; Azepines; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Histones; HL-60 Cells; Humans; K562 Cells; Kinetics; Leukemia; Leukemia, Erythroblastic, Acute; Mice; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Triazoles; Tumor Cells, Cultured

2002

Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line.

Journal of immunology (Baltimore, Md. : 1950), 2004, May-15, Volume: 172, Issue:10

Topics: Adjuvants, Immunologic; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Chromans; Cytokines; Etoposide; Humans; Interleukin-8; KB Cells; Mitomycin; NF-kappa B; Oxidative Stress; Phospholipid Ethers; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transduction, Genetic

2004